STAT3 and Miyoshi myopathy: LLL12, a STAT3 inhibitor, effectively blocked STAT3 phosphorylation, nuclear translocation, DNA binding activity, and induced apoptosis in primary MM cells obtained from patients resistant to lenalidomide and bortezomib [115].